Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...

Black gay men face major PrEP access gaps due to cost, stigma, mistrust, and provider silence—despite high HIV impact; ...

The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...

The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...

HUNTSVILLE, AL (WAFF) - Sept. 18 marks National HIV/AIDS and Aging Awareness Day. Older Americans are more likely than younger Americans to be diagnosed with HIV infection late in the course of their ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving ...

Analysts said that Yeztugo’s forecast, which would represent 433% year-over-year growth, is achievable.

A man who is HIV positive has described how it felt like a "complete sledgehammer blow" when he was first told his diagnosis, but 15 years later it is just "the same as any other chronic illness". "It ...